CXCR4 S338X clonality is an important determinant of ibrutinib outcomes in patients with Waldenström macroglobulinemia.
暂无分享，去创建一个
S. Treon | Z. Hunter | J. Castillo | Guang Yang | Lian Xu | K. Meid | C. Patterson | Xia Liu | Jiaji G. Chen | Manit Munshi | Amanda Kofides | M. Demos | M. L. Guerrera | Andrew Keezer | J. Gustine | N. Tsakmaklis | T. Dubeau | Gloria G. Chan | Nicholas Tsakmaklis